Skip to content

Auto Continuous Positive Airway Pressure (CPAP) Based Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)

Auto CPAP Based Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00750165
Enrollment
32
Registered
2008-09-10
Start date
2007-05-31
Completion date
2008-01-31
Last updated
2019-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructive

Keywords

Obstructive Sleep Apnea, Humidification, Continuous Positive Airway Pressure

Brief summary

Nasal Continuous Positive Airway Pressure (CPAP) is the standard therapy for obstructive sleep apnea hypopnea syndrome (OSAHS). This is most commonly administered as a single positive pressure that has been individualized for the patient to prevent obstructive respiratory events. However, the therapeutic pressure may vary by sleep stage and body position within a single night and may change over the course of several nights. One approach to dealing with this variability is the use of automatically adjusting CPAP that responds to patient breathing patterns with alterations in the delivered pressure. This study is designed to determine the effectiveness of using the energy spectrum analysis of flow signals to automatically adjust CPAP pressure and improve sleep variables. Thirty subjects who require CPAP will be recruited from the NYU sleep disorders center. Following diagnostic studies (either split night or full night) the subject will undergo a night of treatment with the Fisher and Paykel Healthcare AutoPAP. Efficacy of treatment will be evaluated based on normalization of sleep disordered breathing while treated with the AutoPAP.

Interventions

The device is a standard CPAP machine with a built in computer controller that incorporates software for evaluation of the flow signal obtained from the CPAP machine

Sponsors

Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* AHI \>15 on the diagnostic portion of the study * \>18 years of age

Exclusion criteria

* Significant Central Apnea * Congestive Heart Failure * Inability to give informed consent * Patient intolerance to CPAP * Anatomical or physiological conditions making CPAP therapy inappropriate

Design outcomes

Primary

MeasureTime frameDescription
Apnea Hypopnea Index (AHI)1 nightThe Apnea Hypopnea Index (AHI) measure of severity of Obstructive Sleep Apnea (OSA). It is a calculation of the number of apnea events and the number of hypopnea events divided by the total sleep time. Mild OSA is characterized between 5-15 events per hour. Moderate OSA is characterized as 15-30 events per hour. Severe OSA is characterized as greater than 30 events per hour.

Secondary

MeasureTime frameDescription
Percent of Time With Less Than 90% Oxygen Saturation1 NightOxygen saturation is a measurement of the amount of oxygen present in the blood. An oxygen saturation of less than 90% is considered low, resulting in hypoxemia. Normal blood oxygen level is considered between 95-100%.
Respiratory Disturbance Index (RDI)1 NightSimilar to AHI, the RDI is a calculation of the total number of respiratory disturbances in sleep. The calculation includes apneas and hypopneas, but also includes respiratory effort related arousals.
Arousal Index (AI)1 NightThe Arousal Index is a calculation of the frequency of awakenings per hour of sleep. The higher the number, the more awakenings per hour.

Countries

United States

Participant flow

Participants by arm

ArmCount
Titration Night
Treatment with the Fisher & Paykel Sleep Style 200 Auto CPAP device SleepStyle 200 Auto Series CPAP Humidifier: The device is a standard CPAP machine with a built in computer controller that incorporates software for evaluation of the flow signal obtained from the CPAP machine
21
Total21

Baseline characteristics

CharacteristicTitration Night
Age, Continuous51 years
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
21 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
21 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 21
other
Total, other adverse events
6 / 21
serious
Total, serious adverse events
0 / 21

Outcome results

Primary

Apnea Hypopnea Index (AHI)

The Apnea Hypopnea Index (AHI) measure of severity of Obstructive Sleep Apnea (OSA). It is a calculation of the number of apnea events and the number of hypopnea events divided by the total sleep time. Mild OSA is characterized between 5-15 events per hour. Moderate OSA is characterized as 15-30 events per hour. Severe OSA is characterized as greater than 30 events per hour.

Time frame: 1 night

ArmMeasureValue (MEAN)
Titration NightApnea Hypopnea Index (AHI)2.4 events per hour
Secondary

Arousal Index (AI)

The Arousal Index is a calculation of the frequency of awakenings per hour of sleep. The higher the number, the more awakenings per hour.

Time frame: 1 Night

ArmMeasureValue (MEAN)
Titration NightArousal Index (AI)16.2 events per hour
Secondary

Percent of Time With Less Than 90% Oxygen Saturation

Oxygen saturation is a measurement of the amount of oxygen present in the blood. An oxygen saturation of less than 90% is considered low, resulting in hypoxemia. Normal blood oxygen level is considered between 95-100%.

Time frame: 1 Night

ArmMeasureValue (MEAN)
Titration NightPercent of Time With Less Than 90% Oxygen Saturation1.4 percentage of total sleep time
Secondary

Respiratory Disturbance Index (RDI)

Similar to AHI, the RDI is a calculation of the total number of respiratory disturbances in sleep. The calculation includes apneas and hypopneas, but also includes respiratory effort related arousals.

Time frame: 1 Night

ArmMeasureValue (MEAN)
Titration NightRespiratory Disturbance Index (RDI)7.1 events per hour

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026